Published in Eur J Clin Microbiol Infect Dis on January 01, 2006
Cavitary pulmonary disease. Clin Microbiol Rev (2008) 2.31
Disseminated Rhodococcus equi infection in HIV infection despite highly active antiretroviral therapy. BMC Infect Dis (2011) 0.87
Rhodococcus equi: a pathogen in immunocompetent patients. J Family Med Prim Care (2013) 0.75
Rhodococcus equi Sepsis in a Renal Transplant Recipient: A Case Study. Transplant Direct (2015) 0.75
Molecular characterization of Rhodococcus equi isolates in equines. Vet World (2017) 0.75
Rhodococcus equi: an animal and human pathogen. Clin Microbiol Rev (1991) 5.02
Rhodococcus equi: an emerging pathogen. Clin Infect Dis (2002) 2.45
Epidemiology of Rhodococcus equi infections: a review. Vet Microbiol (1997) 1.83
Lung abscess due to Corynebacterium equi. Report of first human infection. Ann Intern Med (1967) 1.76
Survival and replication of Rhodococcus equi in macrophages. Infect Immun (1994) 1.76
Rhodococcus equi infections of humans. 12 cases and a review of the literature. Medicine (Baltimore) (1994) 1.54
Prevalence of virulent Rhodococcus equi in isolates from soil and feces of horses from horse-breeding farms with and without endemic infections. J Clin Microbiol (1991) 1.51
Rhodococcus equi infections in immunocompetent hosts: case report and review. Clin Infect Dis (2001) 1.47
Ecology of Rhodococcus equi. Vet Microbiol (1984) 1.15
Therapy of Rhodococcus equi disseminated infections in nude mice. Antimicrob Agents Chemother (1992) 1.12
Rhodococcus equi brain abscess in an immunocompetent patient. Scand J Infect Dis (2002) 0.84
In vitro activity and human pharmacokinetics of teicoplanin. Antimicrob Agents Chemother (1984) 3.66
GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae. Antimicrob Agents Chemother (1980) 3.61
In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime. Antimicrob Agents Chemother (1981) 3.05
Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis. J Clin Microbiol (1999) 2.20
Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral beta-lactams. J Antimicrob Chemother (2003) 1.73
Prospective evaluation of technetium-99m-HMPAO SPECT in mild and moderate traumatic brain injury. J Nucl Med (1994) 1.58
Evaluation of a new identification system, Crystal Enteric/Non-Fermenter, for gram-negative bacilli. J Clin Microbiol (1995) 1.55
Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis? Clin Microbiol Infect (2011) 1.55
Identification of Corynebacterium amycolatum and other nonlipophilic fermentative corynebacteria of human origin. J Clin Microbiol (1998) 1.53
Differential and enrichment media for selective culture and recognition of yeast species from clinical material. Eur J Clin Microbiol Infect Dis (1995) 1.50
Sexually transmitted infections among married women in Dhaka, Bangladesh: unexpected high prevalence of herpes simplex type 2 infection. Sex Transm Infect (2001) 1.39
Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. Crit Care Med (1997) 1.39
In vitro activity of Ro 13-9904, a new beta-lactamase-stable cephalosporin. Antimicrob Agents Chemother (1981) 1.36
Septicaemia caused by Rahnella aquatilis in an immunocompromised patient. Eur J Clin Microbiol Infect Dis (1988) 1.34
Unsatisfactory performance of flow cytometer UF-100 and urine strips in predicting outcome of urine cultures. J Clin Microbiol (2001) 1.28
Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests. J Antimicrob Chemother (2002) 1.25
Comparison of Copan eSwab with the Copan Venturi Transystem for the quantitative survival of Escherichia coli, Streptococcus agalactiae and Candida albicans. Eur J Clin Microbiol Infect Dis (2010) 1.25
AIDS-associated cryptococcal meningitis in Rwanda (1983-1992): epidemiologic and diagnostic features. J Infect (1999) 1.22
Sexually transmitted infections in a basic healthcare clinic in Dhaka, Bangladesh: syndromic management for cervicitis is not justified. Sex Transm Infect (1999) 1.21
Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium. Acta Clin Belg (1996) 1.20
Clinical evaluation of the Copan ESwab for methicillin-resistant Staphylococcus aureus detection and culture of wounds. Eur J Clin Microbiol Infect Dis (2011) 1.20
Evaluating the "Leeds criteria" for Pseudomonas aeruginosa infection in a cystic fibrosis centre. Eur Respir J (2006) 1.17
Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B. Antimicrob Agents Chemother (2000) 1.11
An outbreak of peritonitis caused by multidrug-resistant Salmonella Typhi in Kinshasa, Democratic Republic of Congo. Travel Med Infect Dis (2009) 1.10
Prospective study of catalase-positive coryneform organisms in clinical specimens: identification, clinical relevance, and antibiotic susceptibility. Diagn Microbiol Infect Dis (1998) 1.09
Endocarditis caused by nutritionally deficient streptococci. Acta Clin Belg (1983) 1.08
Susceptibility of ticarcillin-resistant gram-negative bacilli to different combinations of ticarcillin and clavulanic acid. J Antimicrob Chemother (1986) 1.07
Rothia dentocariosa, endocarditis and mycotic aneurysms: case report and review of the literature. Clin Microbiol Infect (2003) 1.05
Comparative in-vitro activity of RP 59500. J Antimicrob Chemother (1992) 1.03
Disseminated infection by Scedosporium prolificans: an emerging fatality among haematology patients. Case report and review. Ann Hematol (2000) 1.02
Plesiomonas shigelloides meningitis and septicaemia in a neonate: report of a case and review of the literature. J Infect (1989) 1.01
Disappointing dipstick screening for urinary tract infection in hospital inpatients. J Clin Pathol (1998) 1.00
Bacteraemia with Leptotrichia buccalis: report of a case and review of the literature. Acta Clin Belg (1996) 1.00
Breakthrough Saprochaete capitata infections in patients receiving echinocandins: case report and review of the literature. Med Mycol (2010) 1.00
Imported malaria in the 1990s: a review of 101 patients. Eur J Emerg Med (2001) 1.00
Melioidosis brain and lung abscess after travel to Sri Lanka. Clin Infect Dis (1999) 0.99
Evaluation of Bactec high blood volume resin media. Diagn Microbiol Infect Dis (1992) 0.99
Campylobacter fetus as a cause of acute cholecystitis. Br J Surg (1986) 0.98
Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries. Clin Infect Dis (2000) 0.97
Matrix-assisted laser desorption ionization-time of flight mass spectrometry for the identification of bacteria and yeasts in a clinical microbiological laboratory: a review. Acta Clin Belg (2011) 0.97
Antimicrobial resistance and serotypes of Shigella isolates in Kigali, Rwanda (1983 to 1993): increasing frequency of multiple resistance. Diagn Microbiol Infect Dis (1997) 0.96
Three cases of destructive native valve endocarditis caused by Staphylococcus lugdunensis. Eur J Clin Microbiol Infect Dis (2005) 0.94
Haptoglobin phenotype 2-2 overrepresentation in Cys282Tyr hemochromatotic patients. J Hepatol (2001) 0.93
Effect of temocillin in combination with other beta-lactam antibiotics. Antimicrob Agents Chemother (1984) 0.92
Susceptibility testing of Pseudomonas aeruginosa by the Vitek 2 system: a comparison with Etest results. Acta Clin Belg (2005) 0.92
Timely diagnosis of respiratory tract infections: evaluation of the performance of the Respifinder assay compared to the xTAG respiratory viral panel assay. J Clin Virol (2011) 0.91
Fungemia at a tertiary care hospital: incidence, therapy, and distribution and antifungal susceptibility of causative species. Eur J Clin Microbiol Infect Dis (2007) 0.91
Comparison and evaluation of Osiris and Sirscan 2000 antimicrobial susceptibility systems in the clinical microbiology laboratory. J Clin Microbiol (2003) 0.91
Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence. J Thromb Haemost (2011) 0.90
Macrolide resistance in Belgian Streptococcus pneumoniae. J Antimicrob Chemother (2000) 0.90
Bacteraemia caused by Leptotrichia trevisanii in a neutropenic patient. Anaerobe (2010) 0.90
Viral lower respiratory tract infection in the elderly: a prospective in-hospital study. Eur J Clin Microbiol Infect Dis (2003) 0.88
Salmonella typhi osteomyelitis. Arch Orthop Trauma Surg (1994) 0.88
Tibial osteomyelitis due to Aspergillus flavus in a heart transplant patient. Infection (1992) 0.88
False-positive results by the platelia Aspergillus galactomannan antigen test for patients treated with amoxicillin-clavulanate. Clin Vaccine Immunol (2008) 0.87
Optimisation of prenatal group B streptococcal screening. Eur J Clin Microbiol Infect Dis (2003) 0.87
Neonatal sepsis due to Streptococcus pneumoniae. Scand J Infect Dis (1990) 0.87
Subinhibitory concentrations of erythromycin reduce pneumococcal adherence to respiratory epithelial cells in vitro. J Antimicrob Chemother (2000) 0.86
One-year follow-up of technetium-99m-HMPAO SPECT in mild head injury. J Nucl Med (1996) 0.86
Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis. J Cyst Fibros (2012) 0.85
Streptococcus pneumoniae bacteraemia in Belgium: differential characteristics in children and the elderly population and implications for vaccine use. J Antimicrob Chemother (2002) 0.85
Catheter-related bacteremia due to Ewingella americana. Clin Microbiol Infect (2001) 0.85
Salmonella typhimurium serovar Copenhagen highly resistant to fluoroquinolones. J Antimicrob Chemother (1994) 0.84
Single dose minocycline and doxycycline treatment of tick-borne relapsing fever. A double-blind clinical trial in Rwanda. Ann Soc Belg Med Trop (1983) 0.84
A double-blind study comparing safety, tolerability and efficacy of iodixanol 320 mgI/ml and ioxaglate 320 mgI/ml in cerebral arteriography. Eur J Radiol (1993) 0.83
Shigella and gonococcal vulvovaginitis in prepubertal central African girls. Pediatr Infect Dis J (1992) 0.83
Meningitis due to Neisseria meningitidis with intermediate susceptibility to penicillin. Eur J Clin Microbiol Infect Dis (1993) 0.83
In vitro activity of trovafloxacin versus ciprofloxacin against clinical isolates. Eur J Clin Microbiol Infect Dis (1996) 0.83
Rupture of vascular prosthesis in a patient with Yersinia enterocolitica bacteremia. Diagn Microbiol Infect Dis (1985) 0.83
Streptobacillus moniliformis: case report and review of the literature. Acta Clin Belg (2001) 0.82
Bacteremia by Streptobacillus moniliformis: first case described in Spain. Eur J Clin Microbiol Infect Dis (2003) 0.82
Bioprosthetic valve endocarditis caused by Neisseria elongata subspecies nitroreducens. Infection (1996) 0.81
Infection assessment of totally implanted long-term venous access devices. J Vasc Access (2006) 0.81
The importance of the quinolones in antibacterial therapy. J Antimicrob Chemother (1990) 0.81
Zoonotic transmission of Cryptococcus neoformans from a magpie to an immunocompetent patient. J Intern Med (2005) 0.81
A cross-sectional survey of the prevalence of Streptococcus pneumoniae nasopharyngeal carriage in Belgian infants attending day care centres. Clin Microbiol Infect (2004) 0.81
Nosocomial infective endocarditis: should the definition be extended to 6 months after discharge. Clin Microbiol Infect (2008) 0.80
Elderly subjects do not show impaired pneumococcal capsular polysaccharide serotype-specific antibody responses as assessed by a multiplexed bead assay. Clin Immunol (2010) 0.80
Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium. Clin Microbiol Infect (2005) 0.80
Treating respiratory tract infections in ambulatory care in Belgium: fluoroquinolone consumption and resistance development. Int J Antimicrob Agents (2005) 0.80
Salmonella typhimurium and Salmonella enteritidis: changing epidemiology from 1973 until 1992. Eur J Epidemiol (1994) 0.80
Influence of postmortem time on the outcome of blood cultures among cadaveric tissue donors. Eur J Clin Microbiol Infect Dis (2008) 0.79
Haemophilus parainfluenzae endocarditis. Three observations and a review. Acta Clin Belg (1980) 0.79
Peripheral blood T and B lymphocyte subpopulations in infants with acute respiratory syncytial virus brochiolitis. Pediatr Allergy Immunol (1997) 0.79
Natural killer (NK) cell leukaemia in a patient with a B cell non-Hodgkin's lymphoma. Clin Lab Haematol (2000) 0.79
Campylobacter jejuni peritonitis during chronic ambulatory peritoneal dialysis (CAPD). Perit Dial Int (1990) 0.79
Lymphocyte subpopulations in healthy newborn infants: comparison of cord blood values with values five days after birth. J Pediatr (1993) 0.78
Comparative evaluation of three flow cytometers for reticulocyte enumeration. Clin Lab Haematol (1993) 0.78
Campylobacter bacteraemia. Report of 2 cases and review of the literature. Acta Clin Belg (1985) 0.78
Invasive fungal infection in an elderly patient with defective inflammatory macrophage function. Clin Microbiol Infect (2011) 0.78
Antibacterial 5'-O-(N-dipeptidyl)-sulfamoyladenosines. Bioorg Med Chem (2008) 0.78
Outbreak of Klebsiella pneumoniae strain harbouring an AmpC (DHA-1) and a blaSHV-11 in a Belgian hospital, August-December 2006. Euro Surveill (2007) 0.78
Antibiotic management teams in Belgian hospitals: continued improvement in the period from 2007 to 2011. Eur J Clin Microbiol Infect Dis (2014) 0.77